Esophageal Varices Prophylaxis in Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab

Clinical trial NCT06961526 · RECRUITING

Trial details

NCT number: NCT06961526
Sponsor: Tanta University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Esophageal and/or Gastric Varices Hepatocellular Carcinoma (HCC)

Start date: 2025-02-15
Primary completion: 2026-07-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.